Compounded tirzepatide
Sold by Lumora MD · every compounded tirzepatide record
The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.
What you actually pay
Per month
$325
| Medication · Tirzepatide + Glycine, standard (subcutaneous injectable, weekly) | $325 |
|---|
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Tirzepatide + Glycine, standard (subcutaneous injectable, weekly) “Tirzepatide + Glycine $325 through secure checkout” | Per month$325 | Charged today$325 |
We earn nothing from this link. Lumora MD has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
One reading so far. A price history appears here after the next verification pass.
- September 2, 2026 — Entry added to the register
Sourcing and terms
| States | Not disclosed as of September 3, 2026 |
|---|---|
| Prescriber | Asynchronous review |
| Cancellation | “Subscriptions renew automatically until cancelled. Cancel at any time through your account settings or by contacting support@lumoramd.com before your next billing date.” |
Not yet checked: pharmacy, membership and consult fee.
Recorded from lumoramd.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2, 2026 — Text fetcher found nothing at /pricing, /weight-loss, /semaglutide (all 404); the real catalog lives under /medications/. This is the richest recovery in the batch: separate priced product pages for semaglutide and tirzepatide in sublingual/oral-drop form (1, 2, and 3-month supply tiers) AND separate subcutaneous-injectable variants combined with B12 or glycine (5 dose tiers for semaglutide, 6 for tirzepatide, each with its own price, not fully enumerated here). Both drugs are explicitly called 'compounded' ('This formulation combines compounded semaglutide...'). The injectable variants are described only as 'subcutaneous injectable' — never 'vial' — so form is left not-disclosed for those; the drops variants are explicitly 'Sublingual/Oral Drops'.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.